Latest News
LSD Anxiety Data: Definium Hits All Phase 3 Endpoints
Definium Therapeutics has reported positive results from its first Phase 3 LSD anxiety trial. The data push a psychedelic medicine closer to a regulatory filing in a condition that has not seen a new drug approval since 2007. The company said on 12 August that Voyage...
Latest News
The ‘Wild West’ of Peptide Medicine and Who’s Qualified to Prescribe
In the medical field, being “authorized” and “qualified” are two very different things. Authorized generally indicates you have the legal right to practice. Qualified means you have the expertise, experience, and skill needed to practice effectively. The distinction...
Finding AF Before It Strikes: The Case for National Screening
There’s a concerning number of Australians living with a dangerous heart rhythm disorder - and many of them have no idea. Atrial fibrillation (AF) is a condition most people have never heard of and that’s a big problem, because it is already a silent cause of stroke. ...
Creative Biolabs Discusses Antibody Library Screening Workflow
Antibody library screening is widely used to identify antibody fragments, such as scFv, Fab, and single-domain antibodies, from large molecular repertoires. Compared with immunization-dependent approaches, library screening can be especially useful for challenging...
CAR-T Therapy Reaches Solid Tumours for the First Time
China's National Medical Products Administration (NMPA) approved satricabtagene autoleucel (satri-cel) on 22 June 2026, making it the world's first CAR-T cell therapy approved for a solid tumour. Developed by Shanghai-based CARsgen Therapeutics, satri-cel is cleared...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
The Passing of a Scientific Giant: James D. Watson
Renowned molecular biologist James D. Watson has died at the age of 97, his son and the Cold Spring Harbor Laboratory (CSHL) in New York confirmed. The scientist, best known for co-discovering the double helix structure of DNA in 1953, passed away following a brief...
The Rise of Cell and Gene Therapy Hubs Across Northern England
The life sciences landscape in northern England is undergoing a dynamic evolution, driven by the growing importance of advanced therapies such as cell and gene treatments. These innovative approaches, which aim to treat or cure diseases by intervening at the level of...
Current Talent, Skills and Infrastructure in the Life Science Industry
The life science sector encompassing pharmaceuticals, biotechnology, medical technologies, diagnostics and related services is evolving rapidly. Success in this industry no longer rests solely on scientific discovery. Increasingly it depends on the right talent,...
Rewriting the MND Playbook
How AI and Biomarkers Are Accelerating the Fight Against Motor Neurone Disease Every ninety minutes in the United Kingdom, someone receives a diagnosis of Motor Neurone Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS), and every ninety minutes, someone...
Challenges in Life Sciences Real Estate
The commercial real estate market serving the life sciences industry is currently undergoing a complex period of adjustment. The underlying dynamics that once propelled rapid growth, such as enthusiastic venture capital, strong demand from biotech and pharmaceutical...
Age Related T Cell Changes Weaken Vaccine Response in Older People
As the population ages, one of the major challenges facing public health is that vaccines tend to become less effective in older adults. A growing body of research increasingly points to specific changes in T cells, critical components of the immune system, as a key...
First Malaria Treatment Approved for Babies and Young Children
A landmark milestone in global health has been reached as the antimalarial drug Coartem Baby has received approval from the Swiss regulator Swissmedic. It is the first treatment specifically designed for newborns and very young infants suffering from malaria. Bridging...
ProImmune Introduces ProVE SL Monomers to Boost T Cell Research
ProImmune has launched its new ProVE SL (Self-Loading) MHC Class I monomers, positioning these reagents as a next-generation tool for researchers studying antigen-specific CD8+ T cells. The announcement highlights the company’s aim to accelerate T cell research by...
Novo Nordisk Locks Horns with Pfizer in Late Bid for Metsera
Danish pharmaceutical leader Novo Nordisk has made a dramatic late entry into the takeover race for United States biotech Metsera, challenging Pfizer’s earlier agreement and sparking a fierce bidding war in one of the most competitive areas of the life sciences...
Chinese Biotech Industry Shows No Signs of Slowing
The Chinese biotechnology sector continues to accelerate, signing high-value deals and expanding its global footprint even as the United States prepares new restrictions on collaborations and funding. Despite growing geopolitical tensions, China’s biopharma industry...
AI and Early Detection of Dementia: Advancing Life Science Frontiers
Dementia continues to pose a significant challenge in neuroscience and clinical care, affecting millions worldwide. Early detection is pivotal in slowing disease progression and implementing preventive interventions. Life sciences are increasingly leveraging...
UK Life Sciences Growth Spreads Beyond London, Oxford and Cambridge
London, Oxford and Cambridge have long been the heartlands of the UK life sciences sector, but other regions across the country are now rapidly emerging as centres of innovation. The Midlands, the North of England, Scotland and Northern Ireland are developing strong...
The Passing of a Scientific Giant: James D. Watson
Renowned molecular biologist James D. Watson has died at the age of 97, his son and the Cold Spring Harbor Laboratory (CSHL) in New York confirmed. The scientist, best known for co-discovering the double helix structure of DNA in 1953, passed away following a brief...
The Rise of Cell and Gene Therapy Hubs Across Northern England
The life sciences landscape in northern England is undergoing a dynamic evolution, driven by the growing importance of advanced therapies such as cell and gene treatments. These innovative approaches, which aim to treat or cure diseases by intervening at the level of...
Current Talent, Skills and Infrastructure in the Life Science Industry
The life science sector encompassing pharmaceuticals, biotechnology, medical technologies, diagnostics and related services is evolving rapidly. Success in this industry no longer rests solely on scientific discovery. Increasingly it depends on the right talent,...
Rewriting the MND Playbook
How AI and Biomarkers Are Accelerating the Fight Against Motor Neurone Disease Every ninety minutes in the United Kingdom, someone receives a diagnosis of Motor Neurone Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS), and every ninety minutes, someone...
Challenges in Life Sciences Real Estate
The commercial real estate market serving the life sciences industry is currently undergoing a complex period of adjustment. The underlying dynamics that once propelled rapid growth, such as enthusiastic venture capital, strong demand from biotech and pharmaceutical...
Age Related T Cell Changes Weaken Vaccine Response in Older People
As the population ages, one of the major challenges facing public health is that vaccines tend to become less effective in older adults. A growing body of research increasingly points to specific changes in T cells, critical components of the immune system, as a key...
First Malaria Treatment Approved for Babies and Young Children
A landmark milestone in global health has been reached as the antimalarial drug Coartem Baby has received approval from the Swiss regulator Swissmedic. It is the first treatment specifically designed for newborns and very young infants suffering from malaria. Bridging...
ProImmune Introduces ProVE SL Monomers to Boost T Cell Research
ProImmune has launched its new ProVE SL (Self-Loading) MHC Class I monomers, positioning these reagents as a next-generation tool for researchers studying antigen-specific CD8+ T cells. The announcement highlights the company’s aim to accelerate T cell research by...
Novo Nordisk Locks Horns with Pfizer in Late Bid for Metsera
Danish pharmaceutical leader Novo Nordisk has made a dramatic late entry into the takeover race for United States biotech Metsera, challenging Pfizer’s earlier agreement and sparking a fierce bidding war in one of the most competitive areas of the life sciences...
Chinese Biotech Industry Shows No Signs of Slowing
The Chinese biotechnology sector continues to accelerate, signing high-value deals and expanding its global footprint even as the United States prepares new restrictions on collaborations and funding. Despite growing geopolitical tensions, China’s biopharma industry...
AI and Early Detection of Dementia: Advancing Life Science Frontiers
Dementia continues to pose a significant challenge in neuroscience and clinical care, affecting millions worldwide. Early detection is pivotal in slowing disease progression and implementing preventive interventions. Life sciences are increasingly leveraging...
UK Life Sciences Growth Spreads Beyond London, Oxford and Cambridge
London, Oxford and Cambridge have long been the heartlands of the UK life sciences sector, but other regions across the country are now rapidly emerging as centres of innovation. The Midlands, the North of England, Scotland and Northern Ireland are developing strong...
Featured Articles
Further News
AI Giants Nvidia, Microsoft and Google Drive Innovation in Pharma R&D
The intersection of artificial intelligence (AI) and pharmaceutical research is transforming drug discovery, clinical trials, and healthcare innovation. Leading technology companies Nvidia, Microsoft, and Google are spearheading this evolution, applying advanced AI...
Emerging Drug Therapies in the Fight Against Sarcopenia
Why Sarcopenia Matters Sarcopenia, the age-related decline in skeletal muscle mass and strength, has become a growing concern in ageing populations. The condition contributes significantly to frailty, falls, fractures, disability and even mortality, placing an...
Trump’s Proposed Drug Tariff Could Reshape the UK Pharma Landscape
It is unusual for trade policy in the United States to have such a direct impact on the UK life sciences sector, but President Donald Trump’s proposed 100 per cent tariff on branded and patented pharmaceuticals could do just that. If enacted, the measure would impose...
Sustainable and Green Manufacturing Practices in the Life Sciences Industry
The life sciences sector is undergoing a significant transformation as it embraces sustainable and green manufacturing practices. These initiatives aim to reduce environmental impact, enhance operational efficiency, and meet the growing demand for eco-friendly...
Claude for Life Sciences – Major AI Pivot into Drug Discovery and Research
Artificial intelligence company Anthropic is making a significant move into the life sciences sector with the launch of Claude for Life Sciences, a version of its Claude language model platform tailored for scientific research, drug discovery and regulatory workflows....
Genentech Cuts 87 Jobs in Latest Round of Layoffs at South San Francisco HQ
Genentech has carried out another round of workforce reductions, cutting 87 positions at its South San Francisco headquarters. The layoffs, filed last week and set to take effect on September 15, were disclosed in a California Worker Adjustment and Retraining...
Navigating Life with Haemophilia with Pfizer
Life with haemophilia can be challenging but advances in science are helping people with haemophilia to lead active and fulfilling lives. What is Haemophilia? Haemophilia is a family of rare genetic blood disorders caused by a clotting factor deficiency, which...
Microsoft’s Copilot Set to License Harvard Medical School Content
Microsoft is reportedly preparing a major update to its Copilot AI assistant that will let it draw on licensed medical content from Harvard Health Publishing when responding to user queries about healthcare. The development signals a strategic shift toward embedding...
Merck Abandons £1bn UK Expansion, Citing Insufficient Government Support
US pharmaceutical heavyweight Merck has decided to halt its planned £1 billion expansion in the UK, criticising the government for a lack of substantial investment in the life sciences sector. The company, which operates under the name MSD in Europe, announced it will...
Hyperfine Banks on $17.5 Million Public Stock Offering
Medical imaging company Hyperfine, listed on the Nasdaq as HYPR, has announced the pricing of an underwritten public offering of 14 million shares of its Class A common stock at $1.25 per share, yielding gross proceeds of approximately $17.5 million before...
UK Crown Estate Buys Harwell East, Opening 4.5m sq ft for Science & Innovation
The Crown Estate has completed the acquisition of Harwell East, a 221 acre site adjacent to the Harwell Science and Innovation Campus in Oxfordshire. The development could deliver up to 4.5 million square feet of laboratory, research, manufacturing and office space,...
Blood Test for 50+ Cancers Shows Promise in Faster Diagnosis
A new multi cancer blood test developed by the United States biotechnology company Grail has demonstrated in North America the ability to detect a wide range of cancers, including many for which no screening programmes exist, at an early and potentially treatable...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.